Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.

This article has no abstract
Epistemonikos ID: a8fa56f0241c6b1350c66fd4fdbd9d6b452facdf
First added on: Apr 03, 2025